Popova Anna Yurievna, Smirnov Viacheslav Sergeevich, Egorova Svetlana Alexandrovna, Nurmatov Zuridin Sharipovich, Milichkina Angelika Marsovna, Drozd Irina Victorovna, Dadanova Gulzada Saparbekovna, Zhumagulova Gulnara Dzhumadylovna, Danilova Ekaterina Mikhailovna, Kasymbekov Zharkynbek Orozbekovich, Drobyshevskaya Victoria Georgievna, Sattarova Gulsunay Zhumabaevna, Zhimbaeva Oyuna Bayarovna, Ramsay Edward Smith, Nuridinova Zhanylay Nuridinovna, Ivanov Valery Andreevich, Urmanbetova Altynai Keneshpekovna, Totolian Areg Artemovich
Federal Service for the Oversight of Consumer Protection and Welfare, 127994 Moscow, Russia.
Saint Petersburg Pasteur Institute, 197101 St. Petersburg, Russia.
Vaccines (Basel). 2025 Feb 27;13(3):249. doi: 10.3390/vaccines13030249.
Specific prevention of measles, mumps, and rubella (MMR) is the main prerequisite for a radical reduction in the incidence of these infections in the Kyrgyz Republic (KR). An increase in the number of seronegative individuals observed in recent years has led to an increase in measles incidence. This is directly related to a decrease in collective immunity, which provides protection for the population only in conditions of a high density of immunized individuals and their uniform distribution in the population. The only way to estimate the number of immunized individuals is by conducting serological surveys of collective immunity.
The aim was to study the level of collective immunity to the MMR viruses in the KR.
This study involved a cohort of 6617 residents (volunteers) aged 1 to 70 years, formed in accordance with the Rospotrebnadzor program "Assessment of collective immunity to vaccine-preventable and other relevant infections" and stratified by age and region of residence. During the study, participants filled out a questionnaire and gave venous blood samples to determine IgG antibodies to MMR viruses (ELISA using certified Russian test systems).
In December 2023, collective immunity ensured epidemiological well-being only with respect to rubella. The volunteer seropositivity was 94.2% (95% CI: 93.7-94.8). The average measles seropositivity was 78.9% (95% CI: 77.9-79.9). It was significantly lower in children aged 1-17 years and significantly higher than the cohort average in individuals aged ≥18 years. The average mumps seropositivity was 76.4% (95% CI: 75.3-77.4), with the minimum level noted among individuals aged 12-29 years (63.8%; 95% CI: 61.4-66.2). The maximum levels of mumps seropositivity were noted among children aged 6-11 years and older adults who had likely experienced mumps (50-70 years). Seroprevalence distributions by activity correlated with age distributions (all infections).
The system of targeted prophylaxis of vaccine-preventable infections adopted in the KR has contributed to the formation of a high level of rubella collective immunity and, to a lesser extent, measles and mumps immunity. The recent trend towards increases in measles and mumps incidence in the KR requires additional efforts to increase collective immunity to these infections.
特异性预防麻疹、腮腺炎和风疹(MMR)是吉尔吉斯共和国(KR)大幅降低这些感染发病率的主要前提条件。近年来观察到血清阴性个体数量增加,导致麻疹发病率上升。这与群体免疫力下降直接相关,群体免疫力只有在免疫个体高密度且在人群中均匀分布的情况下才能为人群提供保护。估计免疫个体数量的唯一方法是进行群体免疫血清学调查。
目的是研究吉尔吉斯共和国对MMR病毒的群体免疫水平。
本研究纳入了6617名年龄在1至70岁的居民(志愿者)队列,该队列按照俄罗斯消费者权益保护和公益监督局的项目“评估对疫苗可预防及其他相关感染的群体免疫力”组建,并按年龄和居住地区分层。在研究过程中,参与者填写问卷并采集静脉血样,以检测针对MMR病毒的IgG抗体(使用经认证的俄罗斯检测系统进行酶联免疫吸附测定)。
2023年12月,群体免疫力仅在风疹方面确保了流行病学意义上的健康状态。志愿者血清阳性率为94.2%(95%置信区间:93.7 - 94.8)。麻疹血清阳性率平均为78.9%(95%置信区间:77.9 - 79.9)。在1至17岁儿童中显著较低,在≥18岁个体中显著高于队列平均水平。腮腺炎血清阳性率平均为76.4%(95%置信区间:75.3 - 77.4),在12至29岁个体中水平最低(63.8%;95%置信区间:61.4 - 66.2)。腮腺炎血清阳性率最高水平出现在6至11岁儿童和可能患过腮腺炎的老年人(50 - 70岁)中。按活动划分的血清流行率分布与年龄分布相关(所有感染情况)。
吉尔吉斯共和国采用的疫苗可预防感染目标预防体系有助于形成高水平的风疹群体免疫力,在较小程度上也有助于形成麻疹和腮腺炎免疫力。吉尔吉斯共和国近期麻疹和腮腺炎发病率上升的趋势需要做出额外努力以提高对这些感染的群体免疫力。